Pathology Study Design, Conduct, and Reporting to Achieve Rigor and Reproducibility in Translational Research Using Animal Models. (9th January 2019)

• Record Type: Journal Article
• Authors: Everitt, Jeffrey I; Treuting, Piper M; Scudamore, Cheryl; Sellers, Rani; Turner, Patricia V; Ward, Jerrold M; Zeiss, Caroline J
• Is Part Of: ILAR journal. Volume 59:Number 1(2018:Mar.)
• Page Start: 4
• Page End: 12
• Publication Date: 2019-01-09
• Subjects: animal models -- pathology -- preclinical models -- reproducibility -- toxicologic pathology -- toxicology -- translational research; Laboratory animals -- Periodicals; Animal models in research -- United States -- Periodicals; Animal Welfare -- Periodicals; Animals, Laboratory -- Periodicals; Transplantation, Heterologous -- Periodicals; 636.0885
• DOI: 10.1093/ilar/ily020
• Languages: English
• ISSNs: 1084-2020

Abstract

Abstract: In translational research, animal models are an important tool to aid in decision-making when taking potential therapies into human clinical trials. Recently, there have been a number of papers that have suggested limited concordance of preclinical animal experiments with subsequent human clinical experience. Assessments of preclinical animal studies have led to concerns about the reproducibility of data and have highlighted the need for an emphasis on rigor and quality in the planning, conduct, analysis, and reporting of such studies. The incorporation of a wider role for the comparative pathologist using pathology best practices in the planning and conduct of animal model-based research is one way to increase the quality and reproducibility of data. The use of optimal design and planning of tissue collection, incorporation of pathology methods into written protocols, conduct of pathology procedures using accepted best practices, and the use of optimal pathology analysis and reporting methods enhance the quality of the data acquired from many types of preclinical animal models and studies. Many of these pathology practices are well established in the discipline of toxicologic pathology and have a proven and useful track record in enhancing the data from animal-based studies used in safety assessment of human therapeutics. Some of this experience can be adopted by the wider community of preclinical investigators to increase the reproducibility of animal study data.